Insight into appropriate medication prescribing for elderly in the COVID-19 era  

作　　者：Amr S Omar Rasha Kaddoura 

机构地区：[1]Department of Cardiothoracic Surgery,Hamad Medical Coporation,Doha 3050,Qatar [2]Department of Critical Care Medicine,Beni Suef Faculty of Medicine,Beni Suef 62511,Egypt [3]Department of Medicine,Weill Cornell Medical Center in Qatar,Doha 3050,Qatar [4]Department of Pharmacy,Heart Hospital,Hamad Medical Corporation,Doha 3050,Qatar

出　　处：《World Journal of Clinical Cases》2022年第32期12056-12058,共3页世界临床病例杂志

摘　　要：Coronavirus disease 2019(COVID-19)complicates clinical management in elderly population.There is an additional need to properly treat and monitor elderly COVID-19 patients.This paper discusses the inappropriate medication prescribing in the elderly and suggests an updated valid assessment tool considering COVID-19 and its treatment.

关 键 词：Atrial fibrillation Beta blockers COVID-19 ELDERLY 

分 类 号：R563.1[医药卫生—呼吸系统]